Boston Scientific Corporation (BSX)
$43.00-0.72%Close
SELLRECOVERY · day 17
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV14.9%–86.7%
- Market cap
- $63.9B
- Beta
- 0.57
- P/E (TTM)
- 17.34
- IV-%ile
- 71
- IV ATM
- 40.2%
- Short % float
- 2.80%
- Days to cover
- 1.9
- SI change
- -10.9%
- 1W
- +3.42%
- 1M
- -1.98%
- vs SPY 1W
- +3.55%
- vs SPY 1M
- -4.49%
Industry peers
FMP comparable companies · ranked by market cap
- MDTBUYMedtronic Plc$119.1BRECOVERYQ 14$93.01+1.31%
- EWSELLEdwards Lifesciences Corporation$49.1BBEARQ 18$85.27+1.38%
- PENBUYPenumbra, Inc.$12.6BBULLQ 27$320.01+0.03%
- TFXSELLTeleflex Incorporated$5.5BBEARQ 11$124.44-0.92%
- MMSIBUYMerit Medical Systems, Inc.$5.3BBULLQ 13$88.14-1.11%
- LIVNSELLLivaNova PLC$4.2BBEARQ 2$76.37-0.38%
- ATRCSELLAtriCure, Inc.$2.9BBEARQ 20$56.87+0.76%
- CNMDSELLCONMED Corporation$1.4BRECOVERYQ 13$45.55-1.36%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on BSX?
- LOPJLB’s latest quantitative signal on Boston Scientific Corporation (BSX) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is BSX in?
- Boston Scientific Corporation (BSX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Boston Scientific Corporation (BSX) do?
- Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these…